Developing systems for fast evolution of genes in living organisms
Synthetic genetic systems for rapid biomolecular evolution in vivo
This study is exploring new ways to quickly change and improve genes in living organisms, which could help create better treatments for conditions like drug resistance, ultimately benefiting patients with more effective medical options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-10839474 on NIH RePORTER |
What this research studies
This research focuses on creating innovative genetic systems that enable the rapid mutation and evolution of specific genes within living organisms. By utilizing a unique DNA replication system, the project aims to evolve enzymes, proteins, and antibodies quickly to tackle various challenges, including drug resistance. Patients may benefit from advancements in treatments and therapies derived from these evolved biomolecules, which could lead to more effective medical solutions.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals affected by drug-resistant conditions or those requiring advanced therapeutic options.
Not a fit: Patients with conditions that do not involve drug resistance or do not require novel therapeutic interventions may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective treatments for conditions related to drug resistance and other biomedical challenges.
How similar studies have performed: Other research has shown promise in using similar genetic evolution techniques, indicating potential for success in this novel approach.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Liu, Chang C — University of California-Irvine
- Study coordinator: Liu, Chang C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.